BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 99 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is 2.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $720,548 | +225.8% | 35,866 | +313.9% | 0.00% | – |
Q2 2023 | $221,156 | -57.8% | 8,666 | -51.1% | 0.00% | – |
Q4 2022 | $524,572 | +155.9% | 17,722 | +100.9% | 0.00% | – |
Q3 2022 | $205,000 | -30.0% | 8,822 | -49.5% | 0.00% | – |
Q2 2022 | $293,000 | -37.5% | 17,474 | +63.5% | 0.00% | – |
Q1 2022 | $469,000 | -7.9% | 10,687 | +27.9% | 0.00% | – |
Q4 2021 | $509,000 | +82.4% | 8,354 | +24.7% | 0.00% | – |
Q3 2021 | $279,000 | – | 6,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |